A Choline, hydroxide, succinate (2:1), dihydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Choline, hydroxide, succinate (2:1), dihydrochloride Certificate of Suitability (COS). The purpose of a Choline, hydroxide, succinate (2:1), dihydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Choline, hydroxide, succinate (2:1), dihydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Choline, hydroxide, succinate (2:1), dihydrochloride to their clients by showing that a Choline, hydroxide, succinate (2:1), dihydrochloride CEP has been issued for it. The manufacturer submits a Choline, hydroxide, succinate (2:1), dihydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Choline, hydroxide, succinate (2:1), dihydrochloride CEP holder for the record. Additionally, the data presented in the Choline, hydroxide, succinate (2:1), dihydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Choline, hydroxide, succinate (2:1), dihydrochloride DMF.
A Choline, hydroxide, succinate (2:1), dihydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Choline, hydroxide, succinate (2:1), dihydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Choline, hydroxide, succinate (2:1), dihydrochloride suppliers with CEP (COS) on PharmaCompass.